Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.21
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.16 (7.512%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2.21
QED Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EPT Disclosure

13 Aug 2007 10:21

Merrill Lynch International13 August 2007 FORM 38.5 (SUMMARY) Lodge with Company Announcements Office and the Panel. Use a separate form for each class of securities in which dealings have been made. CONNECTED EXEMPT PRINCIPLE TRADER: DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS Name of EPT Merrill Lynch International Date of disclosure 13 August 2007 Date of dealing 10 August 2007 Telephone number 020 7996 2121 Please see attached disclosure of dealings under Rule 38.5 in the securities of the following companies: 10 August 2007 Quintain Estates & Development Plc - Common Friends Provident Plc - Common AMENDMENT state which element(s) of previous disclosure was incorrect: In the case of option business or dealings in derivatives full details should be given on a separate sheet so that the nature of the dealings can be fully understood. For options this should include the number of securities under option, the exercise period (or in the case of exercise, the exercise date), the exercise price and any option money paid or received. For derivatives this should include, at least, the number of reference securities to which they relate (when relevant), the maturity date (or if applicable the closing out date) and the reference price. For full details of disclosure requirements see Rules 8 and 38 of the Code. If in doubt contact the Monitoring Section of the Panel, Tel. No:0207 638 0129 FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN CLIENT-SERVICING CAPACITY (Rule 38.5(a) of The City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of exempt principal trader Merrill Lynch International Company dealt in Quintain Estates & Development Plc Class of relevant security to which the Common dealings being disclosed relate Date of dealing 10/08/2007 2. DEALINGS (a) Purchases and sales Total number of securities Highest price paid Lowest price paid purchased 28,438 GBP 9.44 GBP 9.21 Total number of securities sold Highest price received Lowest price received 63,412 GBP 9.44 GBP 9.11 (b) Derivatives transactions (other than options) Product name, Short/Long Number of securities Price per unit eg. CFD (c) Options transactions in respect of existing securities Product name Writing, Number of Exercise Type, e.g. Type, e.g. Option money selling, securities under price American, American, eg call option purchasing, option European etc European etc paid/received varying etc. per unit (ii) Exercising Product name Number of securities under Exercise price eg call option option 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. Date of disclosure 13/08/2007 Contact name Louise Howard Telephone number +44 20 7996 2121 Name of offeree/offeror with whom connected Quill Securities Limited Nature of connection # Advisor FORM 38.5(a) DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN CLIENT-SERVICING CAPACITY (Rule 38.5(a) of The City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of exempt principal trader Merrill Lynch International Company dealt in Friends Provident Plc Class of relevant security to which the Common dealings being disclosed relate Date of dealing 10/08/2007 2. DEALINGS (a) Purchases and sales Total number of securities Highest price paid Lowest price paid purchased 1,442,726 GBP 1.92 GBP 1.80 Total number of securities sold Highest price received Lowest price received 403,751 GBP 1.88 GBP 1.80 (b) Derivatives transactions (other than options) Product name, Short/Long Number of securities Price per unit eg. CFD (c) Options transactions in respect of existing securities Product name Writing, Number of Exercise Type, e.g. Type, e.g. Option money selling, securities under price American, American, eg call option purchasing, option European etc European etc paid/received varying etc. per unit (ii) Exercising Product name Number of securities under Exercise price eg call option option 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. Date of disclosure 13/08/2007 Contact name Louise Howard Telephone number +44 20 7996 2121 Name of offeree/offeror with whom connected Friends Provident Plc Nature of connection # Advisor This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Jun 20247:00 amRNSExtended agreement with BTG Bioliquids for bioMSAR
29th May 20247:00 amRNSRepresentation Agreement Addendum & Warrants Grant
28th May 20247:00 amRNSOCP Commercial Framework Agreement
2nd May 20247:00 amRNSQuadrise-Vertoro JDA to sea-trial bioMSAR Zero
29th Apr 20247:00 amRNSMarine Project Update
19th Apr 20247:00 amRNSValkor Project Update
12th Apr 20244:58 pmRNSResults of Open Offer
22nd Mar 20243:10 pmRNSExtension of Open Offer Closing Date
20th Mar 20241:01 pmRNSInvestor Presentation
19th Mar 20247:00 amRNSPlacing Results, Open Offer & Posting of Circular
18th Mar 20244:55 pmRNSProposed Placing, Subscription and Open Offer
18th Mar 20244:53 pmRNSInterim Results
15th Feb 20247:00 amRNSAgreement with Euthenia & BTG Bioliquids
6th Feb 20247:00 amRNSMarine Project Update
6th Dec 20237:00 amRNSUpdate re bioMSARâ„¢ and bioMSARâ„¢ Zero Development
27th Nov 20235:46 pmRNSResult of AGM
27th Nov 20237:00 amRNSAGM Statement
22nd Nov 20237:00 amRNSMorocco Project Update
9th Nov 20237:00 amRNSPublication of 2023 Sustainability Report
31st Oct 202312:45 pmRNSMorocco Project Update
27th Oct 20234:20 pmRNSPosting of Annual Report & Notice of AGM
24th Oct 20239:33 amRNSChange of Nominated Adviser
2nd Oct 20237:30 amRNSDirectorate Change
2nd Oct 20237:00 amRNSFinal Results and Notice of AGM
12th Sep 20237:00 amRNSMorocco Project Update
29th Aug 20237:00 amRNSValkor Project Update
24th Aug 202312:29 pmRNSValkor Update
18th Aug 20233:46 pmRNSMorocco Update
4th Aug 20237:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 20234:15 pmRNSDirector/PDMR Shareholding
28th Jul 20234:25 pmRNSDirector/PDMR Shareholding
25th Jul 20233:34 pmRNSResults of Open Offer
7th Jul 202312:00 pmRNSInvestor Presentation
7th Jul 202310:38 amRNSPlacing Results, Open Offer & Posting of Circular
7th Jul 20237:00 amRNSProposed Placing and Open Offer
22nd Jun 20237:00 amRNSMorocco Update
12th Jun 20237:00 amRNSValkor Site License & Supply Agreement
8th Jun 20237:00 amRNSJoint Development Agreement with BTG Bioliquids
26th May 20237:00 amRNSVertoro Joint Development Agreement Update
22nd May 20237:00 amRNSMorocco Update
16th May 20234:29 pmRNSReplacement: Business Update
16th May 20237:00 amRNSBusiness Update
25th Apr 20237:00 amRNSAppointment of Joint Broker
29th Mar 20237:00 amRNSInterim Results
28th Mar 20237:00 amRNSChange of Company Name
22nd Oct 20155:26 pmRNSDelisting of Quintain ordinary shares
15th Oct 20154:30 pmRNSHolding(s) in Company
15th Oct 20154:30 pmRNSHolding(s) in Company
13th Oct 20154:30 pmRNSHolding(s) in Company
13th Oct 20154:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.